Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!

Sun Pharma Consolidated December 2021 Net Sales at Rs 9,863.06 crore, up 11.61% Y-o-Y

January 31, 2022 / 11:32 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Reported Consolidated quarterly numbers for Sun Pharmaceutical Industries are:

Net Sales at Rs 9,863.06 crore in December 2021 up 11.61% from Rs. 8,836.78 crore in December 2020.

Quarterly Net Profit at Rs. 2,058.80 crore in December 2021 up 7.6% from Rs. 1,913.41 crore in December 2020.

EBITDA stands at Rs. 3,038.84 crore in December 2021 up 11.68% from Rs. 2,721.09 crore in December 2020.

Sun Pharma EPS has increased to Rs. 8.60 in December 2021 from Rs. 7.72 in December 2020.

Close

Sun Pharma shares closed at 827.25 on January 28, 2022 (BSE) and has given 6.82% returns over the last 6 months and 40.19% over the last 12 months.

Sun Pharmaceutical Industries
Consolidated Quarterly Resultsin Rs. Cr.
Dec'21Sep'21Dec'20
Net Sales/Income from operations9,814.179,625.938,781.84
Other Operating Income48.89--54.94
Total Income From Operations9,863.069,625.938,836.78
EXPENDITURE
Consumption of Raw Materials1,713.731,584.941,427.60
Purchase of Traded Goods792.37873.58868.34
Increase/Decrease in Stocks134.5263.3437.45
Power & Fuel------
Employees Cost1,850.911,806.271,720.45
Depreciation553.68530.37531.94
Excise Duty------
Admin. And Selling Expenses------
R & D Expenses------
Provisions And Contingencies------
Exp. Capitalised------
Other Expenses2,765.202,667.862,376.80
P/L Before Other Inc., Int., Excpt. Items & Tax2,052.652,099.571,874.20
Other Income432.51222.89314.95
P/L Before Int., Excpt. Items & Tax2,485.162,322.462,189.15
Interest18.9735.9526.10
P/L Before Exceptional Items & Tax2,466.192,286.512,163.05
Exceptional Items------
P/L Before Tax2,466.192,286.512,163.05
Tax335.39197.78244.94
P/L After Tax from Ordinary Activities2,130.802,088.731,918.11
Prior Year Adjustments------
Extra Ordinary Items------
Net Profit/(Loss) For the Period2,130.802,088.731,918.11
Minority Interest-67.48-39.33--
Share Of P/L Of Associates-4.52-2.39-4.70
Net P/L After M.I & Associates2,058.802,047.011,913.41
Equity Share Capital239.93239.93239.93
Reserves Excluding Revaluation Reserves------
Equity Dividend Rate (%)------
EPS Before Extra Ordinary
Basic EPS8.608.507.72
Diluted EPS8.608.507.72
EPS After Extra Ordinary
Basic EPS8.608.507.72
Diluted EPS8.608.507.72
Public Share Holding
No Of Shares (Crores)------
Share Holding (%)------
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
b) Non-encumbered
- Number of shares (Crores)------
- Per. of shares (as a % of the total sh. of prom. and promoter group)------
- Per. of shares (as a % of the total Share Cap. of the company)------
Source : Dion Global Solutions Limited



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes

Sections
ISO 27001 - BSI Assurance Mark